An ertapenem-resistant Klebsiella pneumoniae clinical isolate (KP20) without carbapenemase and negative for the efflux pump inhibition test was resistant to ertapenem at a high level [minimum inhibitory concentration (MIC) = 64 mg/L] but susceptible to meropenem and imipenem. Second-generation sequencing was performed and a termination mutation was found in ramR. Complementation of ramR in KP20 reduced the ertapenem MIC by 128 times (from 64 mg/L to 0.5 mg/L). Overexpression of ramA and loss of OmpK35 were discovered in strain KP20 by quantitative reverse transcription PCR (RT-qPCR) and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), respectively. Furthermore, ramA deletion in strain KP20 resulted in a 128-fold decrease in the MIC of ertapenem (from 64 mg/L to 0.5 mg/L), and expression of OmpK35 was observed in KP20ΔramA by SDS-PAGE. Complementation of ramA in KP20ΔramA led to a 45.45-fold downregulation of ompK35. Complementation of ompK35 in KP20 could restore susceptibility to ertapenem (MIC reduced from 64 mg/L to 0.25 mg/L). Furthermore, results of the electrophoretic mobility shift assay showed that RamA could bind to the promoter of micF. These results showed that the termination mutation in ramR resulted in overexpression of ramA causing loss of OmpK35 expression through upregulation of micF, revealing the mechanism of ertapenem resistance only in K. pneumoniae.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijantimicag.2022.106653 | DOI Listing |
Cureus
February 2025
Internal Medicine, Hamad Medical Corporation, Doha, QAT.
Though globally prevalent, infections rarely progress to bacteremia (shigellemia), particularly in immunocompetent individuals. Here, we report a case of shigellemia with extended-spectrum beta-lactamase (ESBL) in Qatar, involving a 53-year-old immunocompetent male with no significant medical history. The patient presented with a one-day history of frequent loose stools, fever, and mild central abdominal pain.
View Article and Find Full Text PDFS Afr J Infect Dis
February 2025
Department of Surgery, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
Background: Studying the microbial profile and their antibiotic resistance in paediatric appendicitis is essential for tracking susceptibility, guiding treatment choices and ensuring effectiveness. Understanding variations in therapies can improve outcomes and reduce complications. Despite its importance, limited research has been conducted in South Africa on microbial profiles and antibiotic resistance in paediatric appendicitis.
View Article and Find Full Text PDFInvestig Clin Urol
March 2025
Department of Urology, Goldman Urologic Clinic, Seoul, Korea.
Purpose: This study aimed to report the results of Korean Antimicrobial Resistance Monitoring System (KARMS) for uncomplicated cystitis (UC) in 2023.
Materials And Methods: KARMS was established for the surveillance of antimicrobial resistance in urinary tract infections with the cooperation of Korean nationwide medical centers. Data from patients with UC have been collected in the web-based KARMS database.
JAC Antimicrob Resist
April 2025
School of Pharmacy, Clinical Pharmacy Department, Sefako Makgatho Health Sciences University, Ga-Rankuwa, South Africa.
Introduction: Antimicrobial resistance, and specifically carbapenem resistance, have developed into a major challenge globally. Because carbapenems are used increasingly as empirical treatment in the presence of rising ESBL infection, the aim of this study was to determine rational prescribing patterns for empirical use of carbapenems. Clinical guidelines are essential in ensuring responsible use in the local context and are one of the most important elements of antibiotic stewardship programmes.
View Article and Find Full Text PDFTher Adv Infect Dis
February 2025
Department of Medical Research, School of Medicine, China Medical University and Hospital, Taichung 404328, Taiwan.
Background: Urinary tract infection (UTI) is one of the most common bacterial infections in clinical practice. Given the rapid increase in antimicrobial resistance and the scarcity of new antibiotics, along with the absence of individual antibiogram testing in some countries, there is an urgent need for robust surveillance systems.
Objective: This study aimed to provide evidence for the surveillance of resistance, a crucial component in developing national UTI treatment guidelines and guiding empirical therapy decisions.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!